• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > Sarah Teichmann wins the 2011 Colworth Medal

Sarah Teichmann wins the 2011 Colworth Medal

Sarah Teichmann wins the 2011 Colworth Medal

Published on 30 April, 2010

Dr Sarah Teichmann has won the Biochemical Society’s 2011 Colworth Medal. The medal is awarded annually to a biochemist under the age of 35 for outstanding research achievement. The award was made in recognition of her groundbreaking work on elucidating principles of the evolution and dynamics of transcriptional regulatory networks and protein complexes. Sarah joins […]

Bicycle Therapeutics signs license agreement with EPFL and adds SR One and SVLS to Seed Syndicate

Published on 29 April, 2010

“Bicycle Therapeutics Ltd, a new biotechnology company developing a novel technology platform for the identification and optimisation of chemically constrained cyclic peptides with high target specificity and binding affinity, has signed a License agreement with the Ecole Polytechnique Federale de Lausanne (EPFL) in Lausanne, Switzerland and has secured additional seed funding from SR One, the […]

Cancer-causing viruses exploit genetic achilles heel, finds study

Published on 27 April, 2010

“Scientists say some viruses can turn cells into ‘viral hotels’ by exploiting tiny molecules derived from human DNA. The UK study [directed by Cancer Research UK and in collaboration with LMB] found that some viruses can boost microRNA activity to suppress the immune system’s reaction to them.” More…

Potential new target for Asthma treatment discovered

Published on 3 March, 2010

Researchers at LMB, lead by Dr Andrew McKenzie, have discovered a novel cell type that could lead to the development of new treatments for asthma, a disease that affects the lives of 5.4 million people in the UK. The new cells, named nuocytes, are a key early source of Interleukin 13 (IL-13), a crucial immune […]

Studying the Individual Cell

Published on 2 March, 2010

“Researchers are taking advantage of new tools and techniques in imaging, sequencing, and proteomics to zoom in on what single cells are doing … Paul Dear at the MRC Laboratory of Molecular Biology says that single-cell analysis is going to explode — and test the paradigm that all cells in a body have identical genomes. […]

Clocking off: the new science of sleep

Published on 26 February, 2010

“Does your body run like clockwork? As Week 7 fatigue sets in, Michael Hastings writes on what recent discoveries in genetics mean for our sleeping patterns … Dr Michael Hastings is a Cambridge neuroscientist, based at the MRC Laboratory of Molecular Biology, specialising in the molecular neurobiology of circadian body clocks.” More…

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 318
  • Page 319
  • Page 320
  • Page 321
  • Page 322
  • Interim pages omitted …
  • Page 325
  • Go to Next Page »

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2025 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us

This site uses cookies. The LMB may use cookies to analyse how you use our website. We use external analysis systems which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our Privacy and Cookies Policy and are integral to our website. You can delete or disable these cookies in your web browser if you wish, but then our site may not work as it is designed.